Streetbeat News

Regulatory

SPRO

Spero Therapeutics has received clearance for its Investigational New Drug (IND) application for SPR206, aimed at treating multi-drug resistant (MDR) Gram-negative bacterial infections. This development marks a significant step forward in the company's efforts to address a critical need in the healthcare sector for new antibiotics capable of combating resistant bacteria.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:08 pm

APLT

Applied Therapeutics announced that the FDA has accepted and granted priority review to its New Drug Application for Govorestat, aimed at treating Classic Galactosemia. This marks a significant milestone for the company as it moves closer to potentially bringing a new treatment option to patients with this rare metabolic disorder.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:06 pm

FMST

FMSTW

Foremost Lithium has announced its application for a $10M grant from the Government of Canada's Critical Infrastructure Fund, aiming to bolster its lithium mining operations.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:01 pm

STLA

Stellantis NV (NASDAQ:STLA) is recalling nearly 340,000 Jeeps in the U.S. due to risks of the wheel dislodging, potentially causing loss of vehicle control. The recall affects 2021-2023 Jeep Grand Cherokee L and 2022-2023 Jeep Grand Cherokee models. Dealers will replace damaged upper control arm pinch bolts. Additionally, nearly 28,000 Ram Promaster vehicles are being recalled over seat belt warning light issues, with dealers set to inspect and replace the seat belt buckle if necessary.

Portfolio Pulse from Anan Ashraf

February 28, 2024 | 12:58 pm

IFF

IFF has received approval for its SYNERXIA yeasts to be used in biofuel production in Argentina, marking a significant step for the company in the biofuel market.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:30 pm

GOGO

Gogo Inc. has provided its financial guidance for 2024, expecting total revenue to be between $410M and $425M, which is in line with the consensus estimate of $423.49M. The company anticipates adjusted EBITDA to range from $110M to $125M, incorporating operating expenses for strategic initiatives like Gogo 5G and Gogo Galileo, and legal expenses from the SmartSky litigation. Free cash flow is projected to be between $20M and $40M, including $45M in reimbursements from the FCC Reimbursement Program, with capital expenditures estimated at $45M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:18 pm

CANF

Can-Fite BioPharma has received a Notice of Allowance in Canada for its patent application concerning the use of Namodenoson for reducing liver fat in patients with Non-Alcoholic Steatohepatitis (NASH).

Portfolio Pulse from Charles Gross

February 28, 2024 | 12:12 pm

DIS

Florida Governor Ron DeSantis criticized Walt Disney Co. (NYSE:DIS) for cronyism and defended the state's takeover of the district previously controlled by Disney. An audit by the Central Florida Tourism Oversight District (CFTOD) revealed cronyism under Disney's control. DeSantis highlighted the state's success in saving money and promoting local business competition since the takeover. Disney's lawsuit against the state was dismissed by a federal judge, which DeSantis views as a victory and a step forward for Florida.

Portfolio Pulse from Shanthi Rexaline

February 28, 2024 | 12:04 pm

CNTG

Centogene has received a notice from Nasdaq regarding its potential delisting. The company intends to request a hearing to appeal the decision. This development could impact investor confidence and the company's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:37 am

CNTG

Centogene announced it is exploring strategic alternatives to create long-term value after receiving a Nasdaq delisting notice for not meeting the minimum market value requirement.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:33 am